CMA1
Basic information
Region (hg38): 14:24505353-24508265
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (35 variants)
- not_provided (1 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CMA1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001836.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | |||||
| missense | 34 | 36 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 34 | 3 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| CMA1 | protein_coding | protein_coding | ENST00000250378 | 5 | 2913 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 7.59e-9 | 0.0431 | 125014 | 4 | 714 | 125732 | 0.00286 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.75 | 201 | 142 | 1.41 | 0.00000782 | 1589 |
| Missense in Polyphen | 76 | 51.795 | 1.4673 | 604 | ||
| Synonymous | -1.90 | 74 | 55.9 | 1.32 | 0.00000300 | 519 |
| Loss of Function | -0.806 | 11 | 8.47 | 1.30 | 3.56e-7 | 112 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00602 | 0.00604 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.0314 | 0.0314 |
| Finnish | 0.0000924 | 0.0000924 |
| European (Non-Finnish) | 0.0000795 | 0.0000791 |
| Middle Eastern | 0.0314 | 0.0314 |
| South Asian | 0.000392 | 0.000392 |
| Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Major secreted protease of mast cells with suspected roles in vasoactive peptide generation, extracellular matrix degradation, and regulation of gland secretion.;
- Pathway
- Agents Acting on the Renin-Angiotensin System Pathway, Pharmacodynamics;Renin-angiotensin system - Homo sapiens (human);ACE Inhibitor Pathway, Pharmacodynamics;Lung fibrosis;ACE Inhibitor Pathway;Signal Transduction;Peptide hormone metabolism;Metabolism of proteins;Metabolism of Angiotensinogen to Angiotensins;Extracellular matrix organization;Activation of Matrix Metalloproteinases;Degradation of the extracellular matrix;Signaling by SCF-KIT;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.626
Intolerance Scores
- loftool
- 0.477
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.19
Haploinsufficiency Scores
- pHI
- 0.131
- hipred
- N
- hipred_score
- 0.216
- ghis
- 0.403
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.138
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cma1
- Phenotype
- hematopoietic system phenotype; immune system phenotype;
Gene ontology
- Biological process
- angiotensin maturation;extracellular matrix disassembly;midbrain development;basement membrane disassembly;positive regulation of angiogenesis;interleukin-1 beta biosynthetic process;regulation of inflammatory response;cellular response to glucose stimulus
- Cellular component
- extracellular region;extracellular space;cytoplasm;secretory granule;collagen-containing extracellular matrix
- Molecular function
- endopeptidase activity;serine-type endopeptidase activity;serine-type peptidase activity;peptide binding